Amanda Kulick
Impact in
- Aging top 2%
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 2
- Cancer-related Molecular Pathways 2
- Pancreatic and Hepatic Oncology Research 2
-
- Advanced biosensing and bioanalysis techniques 2
- CRISPR and Genetic Engineering 2
- Co-authors
- Scott W. Lowe (6 shared papers)Josef Leibold (4 shared papers)Yu-Jui Ho (5 shared papers)Judith Feucht (2 shared papers)Direna Alonso‐Curbelo (2 shared papers)Elisa de Stanchina (11 shared papers)Alessandra Piersigilli (1 shared paper)Theodoros Giavridis (1 shared paper)
- Journals
- Journal of Nuclear Medicine (2 papers)Cancer Discovery (1 paper)Frontiers in Oncology (1 paper)Science (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Amanda Kulick
13 papers receiving 1.6k citations
Amanda Kulick's Hit Papers
Peers
Comparison fields: 5 of 94
- Aging 95
- Immunology 491
- Physiology 527
- Oncology 518
- Cancer Research 158
Countries citing papers authored by Amanda Kulick
This map shows the geographic impact of Amanda Kulick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Kulick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Kulick more than expected).
Fields of papers citing papers by Amanda Kulick
This network shows the impact of papers produced by Amanda Kulick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Kulick. The network helps show where Amanda Kulick may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Kulick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Senolytic CAR T cells reverse senescence-associated pathologies Hit paper breakdown → | 2020 | 724 |
| 2 | 2020 | 281 | |
| 3 | 2018 | 268 | |
| 4 | 2017 | 104 | |
| 5 | 2021 | 61 | |
| 6 | 2022 | 50 | |
| 7 | 2018 | 35 | |
| 8 | 2017 | 17 | |
| 9 | 2014 | 17 | |
| 10 | 2020 | 7 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2024 | 1 |
About Amanda Kulick
Amanda Kulick is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Biomedical Engineering, having authored 13 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related Molecular Pathways (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Immune cells in cancer (2 papers) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Aging (95 citations), Immunology (491 citations), Physiology (527 citations), Oncology (518 citations) and Cancer Research (158 citations). Amanda Kulick has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Scott W. Lowe, Josef Leibold, Yu-Jui Ho, Judith Feucht, Direna Alonso‐Curbelo, Elisa de Stanchina, Alessandra Piersigilli, Theodoros Giavridis, Scott L. Friedman and Ellinor I.B. Peerschke. Their work appears in journals such as Journal of Nuclear Medicine, Cancer Discovery, Frontiers in Oncology, Science and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.